HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Correspondence: Submit a response Alert me when this article is cited Alert me when Correspondence are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tatum, W. O. Articles by Zachariah, S. B. Search for Related Content PubMed PubMed Citation Articles by Tatum, W. O., IV Articles by Zachariah, S. B.

Gabapentin treatment of seizures in acute intermittent porphyria

From the Department of Neurology (Drs. Tatum and Zachariah), University of South Florida, Tampa; Tampa General Hospital (Dr. Tatum), Tampa; and the Veterans Administration Medical Center (Dr. Zachariah), Bay Pines, FL.

Article abstract—Most antiepileptic drugs (AEDs) available have demonstrated porphyrogenicity in hepatic porphyrias. Gabapentin is a new AED not appreciably metabolized by the liver in humans. We report two patients with acute intermittent porphyria successfully treated with gabapentin without its inducing porphyric crisis.

This article has been cited by other articles:

				W. O. Tatum IV, R. Galvez, S. Benbadis, and E. Carrazana New Antiepileptic Drugs: Into the New Millennium Arch Fam Med, November 1, 2000; 9(10): 1135 - 1141. [Abstract] [Full Text] [PDF]

				H. Thadani, A. Deacon, and T. Peters Regular review: Diagnosis and management of porphyria BMJ, June 17, 2000; 320(7250): 1647 - 1651. [Full Text]

				T. F. Barron and S. L. Hunt A Review of the Newer Antiepileptic Drugs and the Ketogenic Diet Clinical Pediatrics, September 1, 1997; 36(9): 513 - 521. [Abstract] [PDF]